viewAgraFlora Organics International Inc.

AgraFlora Organics International receives cannabis edibles processing licence for its Winnipeg manufacturing facility

The standard processing license from Health Canada is expected to allow the facility to produce more than 250,000 pieces of cannabis edibles per eight-hour shift when fully operational

AgraFlora Organics International Inc. -
AgraFlora's EIC joint venture facility will produce cannabis-activated pectin and gelatin gummies, hard candy, as well as sugar-free variants

AgraFlora Organics International Inc (CSE:AGRA) (OTCPINK:AGFAF) (FRA:PU31) announced that on December 11, 2020, it received a newly-issued standard processing licence from Health Canada for the company’s 51,000-square-foot, fully-automated cannabis edibles manufacturing facility in Winnipeg, Manitoba.

The facility is part of the Edibles and Infusions Corporation (EIC) joint venture formed between AgraFlora and one of North America’s leading confectionary manufacturing families.

“We are delighted to receive the Manufacturing License at our Edibles Facility within our outlined timeframe. Our strong evidence package submission is a testament to the hard-working team we have assembled. We are now able to commercialize our formulations and bring to market cannabis activated pectin and gelatin gummies, hard candy, and sugar-free variants,” EIC co-founder and operational manager James Fletcher said in a statement.

READ: AgraFlora Organics intends to be a top cannabis player in Canada and Europe 

The Winnipeg manufacturing facility, when fully operational, expects to produce more than 250,000 pieces of precisely-dosed edibles per eight-hour shift.   

AgraFlora added that it will continue to focus on completing long-term production relationships through the culmination of the recently-announced Research and Development (R&D) trials through its Health Canada R&D license.

The company recently acquired High Performance Liquid Chromatography (HPLC) equipment for the manufacturing facility, which it says will allow it to rapidly develop and launch new edibles products that have already been formulated.

AgraFlora Organics International grows, distributes and markets premium cannabis and cannabis-infused products. Its strategy is two-pronged: supply the Canadian recreational market with high-potency flower and edible products, while serving the European medical cannabis market. 

The company said it expects to roll out the first cannabis sales in mid 2Q 2021 from cultivation operations at the Propagation Services Canada (PSC) facility in Delta, British Columbia, which it anticipates will produce 10,000 plants yielding 50 grams per plant of saleable product in 2021.

Shares of AgraFlora Organics International gained 33% to $0.04 following the announcement.

Contact Sean at sean@proactiveinvestors.com

Quick facts: AgraFlora Organics International Inc.

Price: 0.055 CAD

Market: CSE
Market Cap: $81.99 m

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of AgraFlora Organics International Inc. named herein, including the promotion by the Company of AgraFlora Organics International Inc. in any...


Full interview: AgraFlora Organics receives Health Canada cultivation...

AgraFlora Organics (CSE: AGRA-OTCPK: AGFAF) Chairman and CEO Brandon Boddy joined Steve Darling from Proactive Vancouver with news the company has received a cultivation license from Health Canada for their delta facility. That facility is the 2nd largest in Canada. Boddy telling Proactive...

on 19/5/20

2 min read